Characterization of a new radioiodinated probe for the α(2C) adrenoceptor in the mouse brain

Neurochemistry International

Volumn 36, Issue 1, 2000, Pages 7-18

  Dossin, Olivier ^a   Moulédous, Lionel ^a   Baudry, Xavier ^a   Tafani, Jean André Mathieu ^b   Mazarguil, Honoré ^a   Zajac, Jean Marie ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; ATIPAMEZOLE; CHLORPROMAZINE; GUANOSINE DERIVATIVE; IODINE 125; MORPHINE; OXYMETAZOLINE; PHENTOLAMINE; PRAZOSIN; PROPRANOLOL; RAUWOLSCINE; RAUWOLSCINE I 125; SODIUM ION; SPIROXATRINE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; BRAIN; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; IN VITRO STUDY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PRIORITY JOURNAL; PUTAMEN; RADIOIODINATION; RECEPTOR DENSITY;

ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BINDING, COMPETITIVE; BRAIN; CAUDATE NUCLEUS; EPINEPHRINE; IODINE RADIOISOTOPES; KINETICS; MALE; MICE; MICE, INBRED STRAINS; MOLECULAR STRUCTURE; ORGAN SPECIFICITY; OXYMETAZOLINE; PRAZOSIN; PUTAMEN; RECEPTORS, ADRENERGIC, ALPHA-2; YOHIMBINE;

EID: 0344289510     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(99)00102-3     Document Type: Article

References (61)

1. 2-adrenoceptors subtypes. Annals of Medicine. 27:1995;439-449.
2. 1 antinociception, tolerance and withdrawal. Journal of Neuroscience. 17:1997;735-744.
3. 3H]atipamezole. European Journal of Pharmacology. 224:1992;27-38.
4. 2C-adrenoceptor-overexpressing mice are impaired in executing non spatial and spatial escape strategies. Molecular Pharmacology. 54:1998;569-576.
5. 3H]idazoxan in rat brain. Journal of Pharmacology and Experimental Therapeutics. 241:1987;1092-1098.
6. 3H]Idazoxan in rat brain. Journal of Pharmacology and Experimental Therapeutics. 241:1987;1079-1091.
7. 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain. British Journal of Pharmacology. 99:1990;803-809.
8. 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Molecular Pharmacology. 42:1992;1-5.
9. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.H., Molinoff P.B., Ruffolo R.R., Trendelenburg U. International union of pharmacology nomenclature of adrenoceptors. Pharmacological Reviews. 46:1994;121-136.
10. 2-adrenoceptor subtypes and a non adrenoceptor imidazoline binding site in rat kidney. European Journal of Pharmacology. 316:1996;359-368.
11. 2-C2 adrenergic receptor. Biochemical and Biophysical Research Communications. 186:1992;1280-1287.
12. 1A receptors in human cerebral cortex. European Journal of Pharmacology. 159:1989;307-310.
13. 3H]RX821002 binding and definition of additional selective drugs. European Journal of Pharmacology. 253:1994;43-49.
14. 2-adrenoceptors. European Journal of Pharmacology. 361:1998;1-15.
15. 3H]rauwolscine? A comparison of nine tissues and cell lines. Journal of Pharmacology and Experimental Therapeutics. 273:1995;1287-1294.
16. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, Australia.
17. Grenhoff J., Svensonn T.H. Clonidine regularizes substantia nigra dopamine cell firing. Life Sciences. 42:1988;2003-2009.
18. 3H]RX821002 as radioligands. Biochimica et Biophysica Acta. 1266:1995;207-214.
19. 2-adrenergic receptors. Molecular Pharmacology. 40:1991;407-412.
20. Hieble J.P., Bondinell W.E., Ruffolo R.R. α- and β-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptors subclassification. Journal of Medicinal Chemistry. 38:1995;3415-3444.
21. 2-adrenoceptors in the rat brain. Molecular Neuropharmacology. 1:1992;219-229.
22. Hunter J.C., Fontana D.J., Hedley L.R., Jasper J.R., Lewis R., Link R.E., Secchi R., Sutton J., Eglen R.M. Assessment of the role of alpha 2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. British Journal of Pharmacology. 122:1997;1339-1344.
23. 2-adrenergic receptor agonists in the rat. Neuroscience. 66:1995;427-432.
24. 2-adrenoceptor agonist. Pharmacology and Toxicology. 72:1993;182-187.
25. 2-adrenergic binding sites. Molecular Pharmacology. 37:1990;876-885.
26. 2-adrenergic receptor. Journal of Pharmacology and Experimental Therapeutics. 29:1986;219-227.
27. 2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system. Neuroscience. 8:1998;1085-1096.
28. 2-C10 homolog responsible for an interspecies variation in antagonist binding. Molecular Pharmacology. 42:1992;16-27.
29. 2-adrenergic receptor subtypes b and c. Science. 273:1996;803-805.
30. 2C-adrenoceptor homolog. Molecular Pharmacology. 48:1995;48-55.
31. 2C adrenoceptors in rat striatum following antisense oligodesoxynucleotide infusion. Molecular Brain Research. 47:1997;267-274.
32. 2A-adrenergic receptor subtype. Science. 273:1996;801-803.
33. Mallard N.J., Hudson A.L., Nutt D.J. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain. British Journal of Pharmacology. 106:1992;1019-1027.
34. 2-adrenoceptors to characterize subtype selectivity of antagonist binding. European Journal of Pharmacology. 246:1993;219-226.
35. McCune S.K., Voigt M.M., Hill J.M. Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain. Neuroscience. 57:1993;143-151.
36. 1A receptors: respective distribution of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain. Neurochemistry International. 19:1991;453-465.
37. Nicholas A.P., Hökfelt T., Pieribone V.A. The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends in Pharmacological Sciences. 17:1996;245-255.
38. Nicholas A.P., Pieribone V., Hökfelt T. Distribution of mRNAs for the alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. Journal of Comparative Neurology. 328:1993;575-594.
39. 3H]RX821002 binding to alpha-2 adrenergic receptor subtypes. Journal of Pharmacology and Experimental Therapeutics. 268:1994;1362-1367.
40. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, Australia.
41. 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system. Journal of Comparative Neurology. 372:1996;135-165.
42. 2-adrenoceptor agonist. Molecular Pharmacology. 51:1997;36-46.
43. Schaak S., Cayla C., Blaise R., Quinchon F., Paris H. HepG2 and SK-N-MC: two human models to study alpha-2 adrenergic receptors of the alpha-2C subtype. Journal of Pharmacology and Experimental Therapeutics. 281:1997;983-991.
44. 2-adrenergic receptor subtype gene expression in rat brain. Molecular Brain Research. 21:1994;133-149.
45. 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system. Journal of Comparative Neurology. 372:1996;111-134.
46. 2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine. European Journal of Pharmacology. 343:1998;93-101.
47. 2C adrenoceptors in the rat striatum and in different regions of the spinal cord. Acta Physiologica Scandinivica. 160:1997;407-412.
48. 3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors. Journal of Pharmacology and Experimental Therapeutics. 271:1994;1558-1565.
49. 2-adrenoceptor. British Journal of Pharmacology. 106:1992;986-995.
50. 3H]-noradrenaline from rat spinal cord. Brain Research Bulletin. 42:1997;129-132.
51. 2 agonist binding sites in the rat and human central nervous system: analysis of some functionnal, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Research Reviews. 7:1984;69-101.
52. 3H]dopamine release from nucleus accumbens slices and monoamines levels in a rat model for attention-deficit hyperactivity disorder. Neurochemical Research. 20:1995;427-433.
53. 3H]rauwolscine. Brain Research. 566:1991;13-20.
54. 1A receptors in human frontal cortex membranes. European Journal of Pharmacology. 207:1991;1-8.
55. 1 receptors in the vertebrate brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 340:1989;486-494.
56. 2-adrenergic receptor subtypes in brain. Pharmacology Biochemistry & Behavior. 41:1992;267-273.
57. 2AAR-receptor gene in transgenic animals. Neuroscience. 74:1996;199-218.
58. 2C- adrenoceptors in the pig cerebellum and kidney cortex. European Journal of Pharmacology. 284:1995;271-279.
59. 3H]rauwolscine binding. Neuroscience. 76:1997;261-272.
60. 2B adrenoceptor mRNA expression during rat brain development. Developmental Brain Research. 100:1997;90-100.
61. Zilles K., Qü M., Schleicher A. Regional distribution and heterogeneity of α-adrenoceptors in the rat central nervous system. Journal für Hirnforschung. 34:1993;123-132.